CM
WVE icon

Crestline Management’s Wave Life Sciences WVE Stock Holding History

Crestline Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-158,336
Closed -$1.96M – 668
2024
Q4 		$1.96M Buy
158,336
+23,076
+17% +$308K 0.07% 287
2024
Q3 		$1.11M Buy
+135,260
New +$809K 0.06% 261

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Crestline Management's WVE Position: Q1 2025 in Review

Crestline Management sold out of Wave Life Sciences (WVE) in Q1 2025, closing a stake of 158,336 shares — an estimated $1.96M sold.

Crestline Management first reported a position in WVE in Q3 2024 and held it in 2 quarters. The position peaked at $1.96M in Q4 2024. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

  • Crestline Management reported no remaining Wave Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 158,336 Wave Life Sciences shares in Q1 2025, an estimated $1.96M.
  • Crestline Management first reported a position in Wave Life Sciences in Q3 2024 and held it in 2 quarters.
  • Crestline Management's Wave Life Sciences position peaked at $1.96M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.